Smith Chas P & Associates PA Cpas boosted its holdings in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 1.7% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 268,570 shares of the company’s stock after buying an additional 4,463 shares during the period. Procter & Gamble makes up about 2.4% of Smith Chas P & Associates PA Cpas’ investment portfolio, making the stock its 14th biggest position. Smith Chas P & Associates PA Cpas’ holdings in Procter & Gamble were worth $42,789,000 at the end of the most recent quarter.
Several other large investors have also bought and sold shares of the business. Unique Wealth LLC lifted its holdings in Procter & Gamble by 2.9% in the first quarter. Unique Wealth LLC now owns 2,141 shares of the company’s stock valued at $365,000 after buying an additional 61 shares during the period. Stableford Capital II LLC increased its stake in Procter & Gamble by 1.1% in the first quarter. Stableford Capital II LLC now owns 5,817 shares of the company’s stock valued at $993,000 after purchasing an additional 61 shares in the last quarter. Bernard Wealth Management Corp. increased its stake in Procter & Gamble by 20.2% in the first quarter. Bernard Wealth Management Corp. now owns 375 shares of the company’s stock valued at $64,000 after purchasing an additional 63 shares in the last quarter. B & T Capital Management DBA Alpha Capital Management increased its stake in Procter & Gamble by 2.3% in the first quarter. B & T Capital Management DBA Alpha Capital Management now owns 2,795 shares of the company’s stock valued at $476,000 after purchasing an additional 63 shares in the last quarter. Finally, Private Management Group Inc. increased its stake in Procter & Gamble by 4.8% in the first quarter. Private Management Group Inc. now owns 1,384 shares of the company’s stock valued at $236,000 after purchasing an additional 64 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several equities research analysts have commented on the stock. UBS Group set a $180.00 target price on shares of Procter & Gamble and gave the company a “buy” rating in a research note on Wednesday, July 30th. Evercore ISI reaffirmed an “in-line” rating and issued a $170.00 target price (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Berenberg Bank upped their target price on shares of Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a research note on Wednesday, September 17th. Wells Fargo & Company lowered their target price on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a research note on Thursday, September 25th. Finally, BNP Paribas reaffirmed an “outperform” rating and issued a $177.00 target price on shares of Procter & Gamble in a research note on Friday, August 15th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and eight have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $173.68.
Procter & Gamble Stock Up 0.6%
Shares of PG stock opened at $153.42 on Tuesday. The firm has a fifty day moving average of $155.97 and a 200-day moving average of $160.39. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a 12-month low of $149.91 and a 12-month high of $180.43. The company has a market capitalization of $359.08 billion, a price-to-earnings ratio of 23.57, a P/E/G ratio of 4.02 and a beta of 0.36.
Procter & Gamble (NYSE:PG – Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. During the same quarter in the prior year, the firm earned $1.40 earnings per share. The firm’s revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities research analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were given a $1.0568 dividend. The ex-dividend date of this dividend was Friday, July 18th. This represents a $4.23 dividend on an annualized basis and a yield of 2.8%. Procter & Gamble’s dividend payout ratio (DPR) is 64.82%.
Insiders Place Their Bets
In related news, CEO Jon R. Moeller sold 40,119 shares of the firm’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $6,309,515.13. Following the completion of the transaction, the chief executive officer owned 319,375 shares of the company’s stock, valued at approximately $50,228,106.25. This trade represents a 11.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Marc S. Pritchard sold 9,849 shares of the firm’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,548,952.23. Following the completion of the transaction, the insider directly owned 182,422 shares of the company’s stock, valued at approximately $28,689,507.94. This trade represents a 5.12% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 120,181 shares of company stock valued at $18,918,012 in the last quarter. Company insiders own 0.20% of the company’s stock.
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories
- Five stocks we like better than Procter & Gamble
- What is the MACD Indicator and How to Use it in Your Trading
- Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300
- What is a penny stock? A comprehensive guide
- Cathie Wood Buys Alibaba and Baidu: Momentum or More Value Ahead?
- Earnings Per Share Calculator: How to Calculate EPS
- This ETF Weeds Out Small-Cap Underperformers
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.